Creative Medical Technology Stock In The News

CELZ Stock  USD 4.97  0.08  1.58%   
Our overall analysis of Creative Medical's news coverage and content from conventional and social sources shows investors' bearish mood towards Creative Medical Technology. The specific impact of Creative Medical news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Creative Medical's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Creative Medical headlines in addition to utilizing other, more conventional financial analysis modules. Check out Creative Medical Backtesting and Creative Medical Hype Analysis.

Creative Medical Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
Creative Medical Technology Holdings Ann...
https://www.globenewswire.com/news-release/2025/02/14/3026567/0/en/Creative-Medical-Technology-Holdings-Announces-Mid-Term-Follow-up-Study-Data-Reporting-Significant-Reduction-in-Opioid-Use-by-Chronic-Lower-Back-Pain-Patients-Undergoing-StemSpine-.html
 Neutral
Macroaxis News: globenewswire.com
Creative Medical Technology Reports Positive One-Year Results for AlloStem™ Type 2 Diabetes Program
https://www.globenewswire.com/news-release/2025/02/11/3024280/0/en/Creative-Medical-Technology-Reports-Positive-One-Year-Results-for-AlloStem-Type-2-Diabetes-Program.html
 Bullish
Macroaxis News: globenewswire.com
Creative Medical Technology Holdings Expands Collaboration with Greenstone Biosciences to Accelerate iPSCelz Pipeline Development
https://www.globenewswire.com/news-release/2025/02/05/3021172/0/en/Creative-Medical-Technology-Holdings-Expands-Collaboration-with-Greenstone-Biosciences-to-Accelerate-iPSCelz-Pipeline-Development.html
 Bullish
Macroaxis News: globenewswire.com
Creative Medical Technology Holdings Ann...
https://www.globenewswire.com/news-release/2025/01/30/3018142/0/en/Creative-Medical-Technology-Holdings-Announces-Positive-Initial-Safety-Tolerability-and-Efficacy-Data-from-First-Cohort-in-Phase-1-2-Trial-of-CELZ-201-DDT-for-Chronic-Back-Pain.html
 Bullish
Yahoo News
10 Penny Stocks to Buy in April
https://finance.yahoo.com/news/10-penny-stocks-buy-april-140550834.html
 Bullish
Yahoo News
10 Penny Stocks That Can Explode in 2022
https://finance.yahoo.com/news/10-penny-stocks-explode-2022-132007047.html
 Bullish
Yahoo News
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
https://finance.yahoo.com/news/today-biggest-pre-market-stock-123744966.html
 Bullish
Yahoo News
8 Top Penny Stocks to Watch Today: EVGRF, PTE, BLCT, GNPX, AFI, CELZ, AUVI, WAVE
https://finance.yahoo.com/news/8-top-penny-stocks-watch-165928042.html
 Bullish
Yahoo News
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
https://finance.yahoo.com/news/today-biggest-pre-market-stock-123726895.html
 Bullish
Yahoo News
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
https://finance.yahoo.com/news/today-biggest-pre-market-stock-122538594.html
 Bullish

Creative Medical Technology Past News Timeline

From Mar 01 to Nov 30Use up and down arrows to move selectionTo Mar 01Use up and down arrows to move upper selectionFrom Nov 30Use up and down arrows to move lower selectionUse TAB select grip buttons or up and down arrows to change selection100%
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Creative and other traded companies coverage with news coverage. We help investors stay connected with Creative headlines for the 1st of March to make an informed investment decision based on correlating the impacts of news items on Creative Stock performance. Please note that trading solely based on the Creative Medical Technology hype is not for everyone as timely availability and quick action are needed to avoid losses.
Creative Medical's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Creative Medical Technology investors visualize upcoming and past events in order to time the market based on Creative Medical Technology noise-free hype analysis.
Creative Medical stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Creative earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Creative Medical that are available to investors today. That information is available publicly through Creative media outlets and privately through word of mouth or via Creative internal channels. However, regardless of the origin, that massive amount of Creative data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Creative Medical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Creative Medical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Creative Medical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Creative Medical alpha.

Creative Largest EPS Surprises

Earnings surprises can significantly impact Creative Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2023-05-12
2023-03-31-0.1-0.070.0330 
2022-05-13
2022-03-31-0.14-0.18-0.0428 
2022-08-12
2022-06-30-0.15-0.2-0.0533 
2022-11-10
2022-09-30-0.13-0.070.0646 
2024-11-12
2024-09-30-0.85-0.750.111 
2023-11-13
2023-09-30-0.86-1.02-0.1618 
View All Earnings Estimates

Creative Medical Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Creative Medical Tec Stock. Current markets are strongly bearish. About 72% of major world exchanges and indexes are down. See today's market update for more information.
Macroaxis News
19th of February 2025
Disposition of 750 shares by Finger Michael H. of Creative Medical at 5.75 subject to Rule...
at MacroaxisInsider 
Yahoo News
14th of February 2025
Creative Medical Technology Holdings Announces Mid-Term Follow-up Study Data Reporting Sig...
at finance.yahoo.com 
Google News at Macroaxis
5th of February 2025
Breakthrough AI Accelerates Diabetes Cure Research as Creative Medical Doubles Development...
at news.google.com 
Google News at Macroaxis
30th of January 2025
Revolutionary Stem Cell Therapy Tackles Chronic Back Pain First Trial Results Unveiled - S...
at news.google.com 
Google News at Macroaxis
11th of December 2024
CELZ stock touches 52-week low at 2.21 amid market challenges - Investing.com
at news.google.com 
Google News at Macroaxis
3rd of December 2024
CELZ stock touches 52-week low at 2.36 amid market challenges - Investing.com
at news.google.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Creative Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Creative Medical's short interest history, or implied volatility extrapolated from Creative Medical options trading.

Additional Tools for Creative Stock Analysis

When running Creative Medical's price analysis, check to measure Creative Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creative Medical is operating at the current time. Most of Creative Medical's value examination focuses on studying past and present price action to predict the probability of Creative Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creative Medical's price. Additionally, you may evaluate how the addition of Creative Medical to your portfolios can decrease your overall portfolio volatility.

Trending Assets

VIRI
VIRI Old
0.00  0.00  0.00 
THER
Therasense
0.0001  0.00  0.00 
ERYP
Erytech Pharma SA
0.00  0.00  0.00 
SONN
Sonnet Biotherapeutics
1.55  0.01  0.65 
VRAX
Virax Biolabs Group
1.67  -0.04  -2.34 
UNCY
Unicycive Therapeutics
0.55  -0.01  -1.79 
ENZC
Enzolytics
0.0008  0.0001  14.29 
ZVSA
ZyVersa Therapeutics
1.13  -0.04  -3.42 
ADXN
Addex Therapeutics
8.50  0.05  0.59 
PALI
Palisade Bio
0.83  0.01  1.22 
PXMD
PaxMedica, Common Stock
0.00  0.00  0.00 
CDIO
Cardio Diagnostics
0.45  -0.04  -8.16 
ICU
LMF Acquisition Oppo
1.73  0.12  7.45 
SNGX
Soligenix
2.25  -0.03  -1.32 
REVB
Revelation Biosciences
3.54  -0.06  -1.67 
QNRX
Quoin Pharmaceuticals
0.31  -0.05  -13.89 
RGBP
Regen BioPharma
0.07  0  6.82 
ATXI
Avenue Therapeutics
1.10  -0.15  -12 
ACGN
Aceragen
0.00  0.00  0.00 
News Freq…Investor S…